HULL HANS (Chief Business Officer) sold 5.0% of their position (9.79K shares) of PLIANT THERAPEUTICS, INC. on the open market
Open‑market sale worth $168.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/19/2024ACC: 0001746473-24-000004
Officer· Chief Business Officer
Since Jun 2020
-9.79K
Net shares
Net seller
$168.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
9.79K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.79K
Price / share
$17.23
Trade value
$168.61K
% of position
5.0%
1/17/2024
194.85K→185.07K
Total
Net shares
−9.79K
Net value
-$168.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/17/2024 | S · Sale | −9.79K | $17.23 | $168.61K | 5.0% | 194.85K | 185.07K |
| Total | −9.79K | -$168.61K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned13.98K
Common Stock
IndirectShares owned3.82K
Common Stock
IndirectShares owned13.98K
Total
31.79K indirect31.79K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 13.98K | Indirect |
| Common Stock | 3.82K | Indirect |
| Common Stock | 13.98K | Indirect |
| Total | 31.79K | 31.79K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported